Skip to content

Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year

Dr Jack Stone at IAS 2025. He is wearing a pale brown suit and has glasses. He's talking into a microphone behind a podium.

Treatment changes do not reduce weight in people with HIV

Dr Graeme Moyle at IAS 2025. He is sitting on a grey chair and talking into a microphone. He's wearing a pale blue top.

Once-monthly oral PrEP moves into late-stage trials

Professor Kenneth Mayer at IAS 2025. He is wearing a dark suit and talking into a microphone at a podium.

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

A woman in a white coat and blue gloves in a laboratory holds a pipette.

Resistance is a growing concern amid rising use of doxyPEP

Left to right: Jean-Michel Molina, Elizabeth Bukusi, Annie Luetkemeyer, Mark Hull and Troy Grennan at the doxyPEP symposium at IAS 2025. The panel are sitting on a stage.

“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025

Professor Linda-Gail Bekker at IAS 2025. She has short grey hair and is wearing a black top. She's standing behind a podium.

Rwanda’s HIV leadership on display at IAS 2025

Rwanda's health minister Dr Sabin Nsanzimana gives a call to action during the session at IAS 2025. He is standing at a podium on a stage with the other session speakers sitting nearby.

Coming soon: news from IAS 2025

Coming soon: news from IAS 2025

Are automated campaigns driven by AI the future of HIV prevention?

Two young people are looking at their phones.